Macitentan (ACT-064992), a Tissue-Targeting Endothelin Receptor Antagonist, Enhances Therapeutic Efficacy of Paclitaxel by Modulating Survival Pathways in Orthotopic Models of Metastatic Human Ovarian Cancer
Titel:
Macitentan (ACT-064992), a Tissue-Targeting Endothelin Receptor Antagonist, Enhances Therapeutic Efficacy of Paclitaxel by Modulating Survival Pathways in Orthotopic Models of Metastatic Human Ovarian Cancer
Auteur:
Kim, Sun-Jin Kim, Jang Seong Kim, Seung Wook Brantley, Emily Yun, Seok Joong He, Junqin Maya, Marva Zhang, Fahao Wu, Qiuyu Lehembre, François Regenass, Urs Fidler, Isaiah J.
Verschenen in:
Neoplasia
Paginering:
Jaargang 13 (2011) nr. 2 pagina's 167-179, IN11-IN12